State-by-State GLP-1 Prescribing Rules: Where You Can (and Can't) Get Prescribed Online
GLP-1 telehealth is legal everywhere, but the rules governing clinician involvement, async prescribing, and interstate prescribing vary. The practical state-by-state map for 2026.
GLP-1 telehealth prescribing is legal in all 50 states — but the rules governing how a prescription can be issued, what clinician involvement is required, and which medications are available vary by state. Here's the practical map for 2026.
The baseline federal framework
At the federal level, semaglutide and tirzepatide are not controlled substances — no DEA registration is required to prescribe them, and there's no federal restriction on telehealth prescribing for these drugs specifically. The federal floor allows telehealth prescribing for non-controlled substances with fewer restrictions than apply to opioids or stimulants.
What matters is state law, which governs: (1) what constitutes a valid patient-provider relationship, (2) whether asynchronous (no real-time interaction) prescribing is permitted, and (3) whether out-of-state telehealth providers can prescribe to in-state patients.
State categories (mid-2026)
| Category | States | What it means |
|---|---|---|
| Permissive async | Most states (~35) | Asynchronous review by a provider (no real-time video required) is sufficient for GLP-1 prescribing. Most telehealth platforms operate under this framework. |
| Video required | ~8–10 states, including IL (pending), CO (existing) | First prescription requires a synchronous video visit. Follow-up may be async. Platforms must support video for patients in these states. |
| Active regulatory review | CA, NY, TX (post-Yale study) | Medical boards reviewing standards; no new requirement yet but watch for updates Q3–Q4 2026. |
Your prescriber must be licensed in the state where you're located at the time of the visit — not where the platform is headquartered. Platforms with multi-state physician networks cover all 50 states; narrower networks may not cover your state. Always verify your state is covered before completing intake and paying.
States with specific GLP-1 compounding restrictions (as of mid-2026)
No state has prohibited GLP-1 prescribing specifically. Some states have pharmacy board guidance on compounding standards that restrict which 503A compounders can operate. The FDA's federal compounding guidance (503B exclusion, comment period closed June 2026) is separate from state restrictions and would apply nationally if finalized.
Verified telehealth providers
50-state coverage. Broad state prescribing network, async and video.
Paid link Get started →Broad state coverage. Video and async options depending on state.
Paid link Get started →